AOGIN India Policy Statement on the Use of HPV Vaccination for Cervical Cancer Elimination

Nearly one-fifth of the worldwide burden of cancer-related deaths among Indian women is attributable to cervical cancer. The World Health Organization (WHO) mandates that 90% of adolescent girls receive the HPV vaccine by age 15 to achieve cervical cancer elimination. Integrating the HPV vaccine into the Universal Immunization Program is necessary to accomplish this in India.

To provide clarity on HPV vaccination dosage, schedules, and delivery methods, AOGIN India has developed this policy statement based on the most recent evidence from both India and around the world, including data from single-dose efficacy trials.

To facilitate the rapid and efficient expansion of vaccination, this document offers evidence-based recommendations for health care professionals, policymakers, and program managers.

AOGIN India is the national chapter of the Asia Oceania Research Organization in Genital Infection & Neoplasia, working to promote education, training, community-based interventions, and research for cervical cancer prevention. This policy statement aims to reduce disparities in access to HPV vaccination and accelerate India's progress toward the WHO's 90-70-90 elimination targets by translating scientific evidence into context-specific guidelines.